Adaptive Biotechnologies Corp Quarterly Return On Equity in % from Q3 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Adaptive Biotechnologies Corp quarterly/annual Return On Equity history and growth rate from Q3 2020 to Q3 2024.
  • Adaptive Biotechnologies Corp Return On Equity for the quarter ending September 30, 2024 was -74.5 %, a 56.5% decline year-over-year.
  • Adaptive Biotechnologies Corp annual Return On Equity for 2023 was -60.5 %, a 52.8% decline from 2022.
  • Adaptive Biotechnologies Corp annual Return On Equity for 2022 was -39.6 %, a 27.6% decline from 2021.
  • Adaptive Biotechnologies Corp annual Return On Equity for 2021 was -31 %, a 37.8% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -74.5 -26.9 -56.5% Jul 1, 2024 Sep 30, 2024
Q2 2024 -72 -28.9 -67% Apr 1, 2024 Jun 30, 2024
Q1 2024 -64.2 -23 -55.7% Jan 1, 2024 Mar 31, 2024
Q4 2023 -60.5 -20.9 -52.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -47.6 -6.67 -16.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 -43.1 -3.2 -8.02% Apr 1, 2023 Jun 30, 2023
Q1 2023 -41.2 -4.54 -12.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -39.6 -8.57 -27.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -41 -13.9 -51.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -39.9 -16.6 -71.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -36.7 -14.3 -63.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 -31 -8.5 -37.8% Oct 1, 2021 Dec 31, 2021
Q3 2021 -27.1 -6.92 -34.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -23.3 Apr 1, 2021 Jun 30, 2021
Q1 2021 -22.4 Jan 1, 2021 Mar 31, 2021
Q4 2020 -22.5 Oct 1, 2020 Dec 31, 2020
Q3 2020 -20.2 Jul 1, 2020 Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.